Switching therapy from natalizumab to fingolimod in relapsing-remitting multiple sclerosis: clinical and magnetic resonance imaging findings. Rinaldi F, Seppi D, Calabrese M, Perini P, Gallo P Mult Scler. 2012 Nov; 18(11):1640-3. PMID: 23100526. Abstract CommentRecommendBookmarkWatch